Skip to main content

LAZARD ASSET MANAGEMENT LLC

Position in CHRS — Coherus Oncology, Inc.

CIK 1207017 NEW YORK, NY

Position in CHRS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$17,768
-$901,310 QoQ
Shares Held
10,514
-98.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CHRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LAZARD ASSET MANAGEMENT LLC holds $400,660,289 across 59 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CHRS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $17,768 10,514
2024-09-30 $919,078 883,729
2024-06-30 $1,091,192 630,747
2024-03-31 $926,603 387,700
2023-12-31 $44,598 13,393
2023-09-30 $1,707,627 456,585
2023-06-30 $2,350,733 550,523
2023-03-31 $2,580,957 377,333
2022-12-31 $2,516,358 317,722
2022-09-30 $1,546,979 160,976
2022-06-30 $59,527 8,222
2022-03-31 $295,484 22,888
2021-12-31 $740,129 46,374
2021-09-30 $126,037 7,843
2021-06-30 $307,261 22,217
2021-03-31 $1,242,960 85,076
2020-12-31 $1,041,009 59,897